Women's Health

Among postmenopausal women, researchers observed no significant associations between ovarian steroids, adrenal hormones, insulin-like growth factor I, parathormone and vitamin D and handgrip strength, according to study results.

Bias based on size during pregnancy is a common experience particularly for women with overweight or obesity and can delay prenatal and postnatal care for women who fear weight stigma in the health care setting, according to experts.

Residential exposure to traffic noise was linked to an increased risk for tinnitus, a finding that researchers said adds to the evidence of traffic noise as a growing health burden.

Pregnancy and lactation-associated osteoporosis is an uncommon diagnosis, but one that has substantial impact on fracture risk for mothers. The condition also may increase osteoporosis risk for their children later in life, an expert said.

Women who use oral contraceptives are more likely to have an aldosterone-to-renin ratio above the threshold for a positive test for primary aldosteronism than those who do not use oral contraceptives, according to study data.

In these videos, Preeya K. Gupta, MD, FACS, associate professor of ophthalmology at Duke University, talks about the various treatment options for dry eye, both approved and in the pipeline, as well as challenges in diagnosis.

Increased phthalate metabolite concentrations may contribute to obesity, glucose impairment and dislipidemia among women with polycystic ovary syndrome, according to study findings published in Clinica Chimica Acta.

Approximately 27% of women in the workplace experience difficulties at work caused by symptomatic menopause, according to a cross-sectional analysis of the Health and Employment After Fifty study.

Magnesium supplementation for 10 weeks led to no beneficial effects for women with polycystic ovary syndrome experiencing hyperandrogenism, hirsutism and impaired sleep quality, researchers reported in Health Science Reports.

Two studies published in Menopause demonstrated hormone therapy and selective serotonin reuptake inhibitors/serotonin norepinephrine reuptake inhibitors as generally effective therapies for menopausal symptoms.